New Zealand markets closed

Kezar Life Sciences, Inc. (KZR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.6844-0.0043 (-0.62%)
At close: 04:00PM EDT
0.7100 +0.03 (+3.74%)
After hours: 07:25PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 49.83M
Enterprise value -111.69M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.11
Price/book (mrq)0.29
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.06

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 3-76.22%
S&P500 52-week change 322.26%
52-week high 33.1300
52-week low 30.6700
50-day moving average 30.8170
200-day moving average 30.9475

Share statistics

Avg vol (3-month) 3715.64k
Avg vol (10-day) 3539.06k
Shares outstanding 572.8M
Implied shares outstanding 673.39M
Float 852.48M
% held by insiders 114.84%
% held by institutions 161.60%
Shares short (15 May 2024) 43.71M
Short ratio (15 May 2024) 45.73
Short % of float (15 May 2024) 45.21%
Short % of shares outstanding (15 May 2024) 45.09%
Shares short (prior month 15 Apr 2024) 43.82M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,491.77%

Management effectiveness

Return on assets (ttm)-27.01%
Return on equity (ttm)-48.07%

Income statement

Revenue (ttm)7M
Revenue per share (ttm)0.10
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -103.36M
Net income avi to common (ttm)-101.33M
Diluted EPS (ttm)-1.3900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)179.8M
Total cash per share (mrq)2.47
Total debt (mrq)18.29M
Total debt/equity (mrq)10.81%
Current ratio (mrq)11.48
Book value per share (mrq)2.32

Cash flow statement

Operating cash flow (ttm)-83.65M
Levered free cash flow (ttm)-46.65M